MRI Study of 1,831 Children Identifies 3 ADHD Brain Profiles, Including 45-Region Severe Biotype
Updated
Updated · Earth.com · May 18
MRI Study of 1,831 Children Identifies 3 ADHD Brain Profiles, Including 45-Region Severe Biotype
1 articles · Updated · Earth.com · May 18
A JAMA Psychiatry study used MRI data from 1,831 children to separate ADHD into three brain-based profiles, including a newly defined severe-combined form centered on emotional dysregulation.
That subgroup showed structural differences in 45 brain regions—versus 26 and 11 in the other profiles—with disruptions concentrated in the medial prefrontal cortex and pallidum, areas tied to emotion, motivation and impulse control.
Chemical mapping also split the profiles: the severe group aligned with serotonin, dopamine, acetylcholine and histamine systems, suggesting standard dopamine-focused stimulants may not fit all children with the same ADHD diagnosis.
Over 4 years of follow-up, emotional problems persisted in the severe group, and about 25% developed mood disorders, compared with under 10% in the other two biotypes.
The scan-based clusters were reproduced in a separate cohort of 554 children, though researchers said the method is not yet ready to diagnose individual patients.
As brain scans reveal ADHD's biological roots, are traditional behavioral diagnoses becoming obsolete for guiding treatment?
What new therapies can target the emotional dysregulation found in the most severe ADHD biotype?
Will advanced brain scans for ADHD diagnosis be affordable for all, or create a new healthcare gap?
Landmark MRI Study Identifies Three Distinct Neurobiological Biotypes of ADHD, Paving the Way for Personalized Treatment
Overview
A major MRI study in 2026 analyzed brain scans from over 1,800 children and used advanced data-driven methods to identify three distinct neurobiological biotypes of ADHD. By applying morphometric similarity networks and the HYDRA algorithm, researchers were able to objectively classify ADHD into biologically different subtypes, moving beyond traditional symptom-based diagnoses. The findings were validated in an independent group, confirming their reliability. This discovery marks a pivotal shift in understanding ADHD, transitioning from a purely behavioral view to one based on brain biology, and opens the door to more personalized treatment strategies in the future.